| Literature DB >> 35566374 |
Valentina Sallustio1, Ilaria Chiocchio2, Manuela Mandrone2, Marco Cirrincione3, Michele Protti3, Giovanna Farruggia4, Angela Abruzzo1, Barbara Luppi1, Federica Bigucci1, Laura Mercolini3, Ferruccio Poli2, Teresa Cerchiara1.
Abstract
Valorization of wild plants to obtain botanical ingredients could be a strategy for sustainable production of cosmetics. This study aimed to select the rosehip extract containing the greatest amounts of bioactive compounds and to encapsulate it in vesicular systems capable of protecting their own antioxidant activity. Chemical analysis of Rosa canina L. extracts was performed by LC-DAD-MS/MS and 1H-NMR and vitamins, phenolic compounds, sugars, and organic acids were detected as the main compounds of the extracts. Liposomes, prepared by the film hydration method, together with hyalurosomes and ethosomes, obtained by the ethanol injection method, were characterized in terms of vesicle size, polydispersity index, entrapment efficiency, zeta potential, in vitro release and biocompatibility on WS1 fibroblasts. Among all types of vesicular systems, ethosomes proved to be the most promising nanocarriers showing nanometric size (196 ± 1 nm), narrow polydispersity (0.20 ± 0.02), good entrapment efficiency (92.30 ± 0.02%), and negative zeta potential (-37.36 ± 0.55 mV). Moreover, ethosomes showed good stability over time, a slow release of polyphenols compared with free extract, and they were not cytotoxic. In conclusion, ethosomes could be innovative carriers for the encapsulation of rosehip extract.Entities:
Keywords: Rosa canina L. extract; antioxidant activity; cosmetic ingredients; cytotoxicity; ethosomes; hyalurosomes; liposomes; polyphenols; skin retention
Mesh:
Substances:
Year: 2022 PMID: 35566374 PMCID: PMC9104920 DOI: 10.3390/molecules27093025
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Content of ascorbic acid and phenolic compounds from the extract of RCF, RCD, and RCL.
| Sample | Ascorbic Acid * | Catechin * | Cyanidin * | Quercetin * | Gallic Acid * |
|---|---|---|---|---|---|
| RCF | 4.03 ± 0.32 | 7.79 ± 0.62 | 5.32 ± 0.49 | 3.01 ± 0.28 | 0.81 ± 0.18 |
| RCD | 4.48 ± 0.31 | 8.80 ± 0.59 | 5.91 ± 0.38 | 3.66 ± 0.24 | 0.88 ± 0.15 |
| RCL | 5.59 ± 0.36 | 12.27 ± 0.74 | 6.87 ± 0.42 | 4.38 ± 0.30 | 1.12 ± 0.13 |
* µg/mg extract ± SD.
TPC, TFC, and AA% of Rosa canina L. extracts.
| Type of Extract | TPC | TFC | AA% |
|---|---|---|---|
| RCF | 68.70 ± 0.46 | 23.16 ± 0.62 | 85.02 ± 0.47 |
| RCD | 88.71 ± 0.95 | 25.38 ± 0.49 | 74.50 ± 0.23 |
| RCL | 128.63 ± 1.03 | 26.43 ± 0.18 | 88.83 ± 0.70 |
Figure 11H−NMR profiling of RCL extract. 1 = aromatic compounds, 2 = sucrose, 3 = α−glucose, 4 = β−glucose, 5 = malic acid, 6 = citric acid, 7 = quinic acid. TMSP = tetramethylsylilpropionic acid (internal standard).
Figure 2FT−IR spectrum of RCL extract.
VS, PDI, ζ potential and EE of LP, HYA, and ET, unloaded and loaded with RCL extract.
| Size (nm) | PDI | ζ (mV) | EE% | ||||
|---|---|---|---|---|---|---|---|
| Unloaded | Loaded | Unloaded | Loaded | Unloaded | Loaded | Loaded | |
| LP | 375 ± 27 | 1971 ± 191 | 0.23 ± 0.19 | 0.45 ± 0.01 | −66.66 ± 1.40 | −47.22 ± 3.23 | 65.50 ± 0.29 |
| HYA | 451 ± 19 | 2236 ± 68 | 0.29 ± 0.10 | 0.32 ± 0.10 | −83.59 ± 2.59 | −56.17 ± 3.95 | 63.97 ± 0.35 |
| ET | 127 ± 1 | 196 ± 2 | 0.14 ± 0.40 | 0.20 ± 0.02 | −46.99 ± 0.93 | −37.36 ± 0.55 | 92.30 ± 0.02 |
Figure 3Size of unloaded (ET) and loaded ethosomes (ET RCL) during 20 weeks of storage at 4.0 ± 1.0 °C.
Figure 4In vitro release of TPC in PBS:EtOH (7:3 v/v) from ET RCL and RCL solution.
Release kinetic parameters for ET RCL.
| Sample | Zero-Order (R2) | First-Order (R2) | Highuci (R2) | Korsmeyer–Peppas (R2) |
|---|---|---|---|---|
| ET RCL | 0.977 | 0.969 | 0.951 | 0.976 ( |
Figure 5In vitro skin retention of TPC from RCL solution and ET RCL after 6h and 24 h.
Figure 6MTT assays on WS1 cells treated for 24 h with increasing concentration of ET, RCL solution, and ET RCL. Effects on cell viability were tested in comparison with control cells (* p < 0.05).